Citation Impact
Citing Papers
Patterns of Cancer Incidence, Mortality, and Prevalence Across Five Continents: Defining Priorities to Reduce Cancer Disparities in Different Geographic Regions of the World
2006 Standout
Current and future colorectal cancer screening strategies
2022
Vaccination to prevent T cell subversion can protect against persistent hepacivirus infection
2019
The Spring α-Helix Coordinates Multiple Modes of HCV (Hepatitis C Virus) NS3 Helicase Action
2016 StandoutNobel
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2024 Standout
Cancer statistics, 2018
2018 Standout
Nonalcoholic steatohepatitis
1996
Pan-Genotype Hepatitis E Virus Replication in Stem Cell–Derived Hepatocellular Systems
2017 StandoutNobel
Human pluripotent stem cell-derived hepatocytes support complete replication of hepatitis C virus
2012
Acromegaly
2006 Standout
Treatment predictors of a sustained virologic response in hepatitis B and C
2008
Vaccination for hepatitis C virus: closing in on an evasive target
2011
Nonstructural protein 3‐4A: the Swiss army knife of hepatitis C virus
2011
Genetic variation in IL28B and spontaneous clearance of hepatitis C virus
2009 StandoutNature
Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection
2011
Colonoscopy in Colorectal-Cancer Screening for Detection of Advanced Neoplasia
2006
Peginterferon Alfa-2b or Alfa-2a with Ribavirin for Treatment of Hepatitis C Infection
2009
Hepatitis C virus—host interactions, replication, and viral assembly
2012
Multi-input chemical control of protein dimerization for programming graded cellular responses
2019 StandoutNobel
Quality in the technical performance of colonoscopy and the continuous quality improvement process for colonoscopy: recommendations of the U.S. Multi-Society Task Force on Colorectal Cancer
2002
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
2005 Standout
Unconventional miR-122 binding stabilizes the HCV genome by forming a trimolecular RNA structure
2013 StandoutNobel
American College of Gastroenterology Guidelines for Colorectal Cancer Screening 2008
2009
Nonalcoholic Fatty Liver Disease
2002 Standout
Barriers of hepatitis C virus interspecies transmission
2012
Lethal Mutagenesis of Hepatitis C Virus Induced by Favipiravir
2016 StandoutNobel
Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas
2004 StandoutNobel
Diuretic Therapy
1998
The Molecular Basis of Drug Resistance against Hepatitis C Virus NS3/4A Protease Inhibitors
2012
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
New advances in the molecular biology of hepatitis C virus infection: towards the identification of new treatment targets
2012
The protease inhibitor, GS-9256, and non-nucleoside polymerase inhibitor tegobuvir alone, with ribavirin, or pegylated interferon plus ribavirin in hepatitis C
2011
Colorectal cancer
2013 Standout
The role of resistance in HCV treatment
2012
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
Screening for colorectal cancer
2005
Effect of Screening Colonoscopy on Colorectal Cancer Incidence and Mortality
2009
A Human Monoclonal Antibody Targeting Scavenger Receptor Class B Type I Precludes Hepatitis C Virus Infection and Viral Spread In Vitro and In Vivo
2011 StandoutNobel
Chronic Idiopathic Thrombocytopenic Purpura
1994
Pegylated Interferon‐α‐2a plus Ribavirin for Treatment‐Naive Asian Patients with Hepatitis C Virus Genotype 1 Infection: A Multicenter, Randomized Controlled Trial
2008
Antiviral strategies in hepatitis C virus infection
2012
Drug discovery for a new generation of covalent drugs
2012
Immune Thrombocytopenic Purpura
2002 Standout
The ins and outs of hepatitis C virus entry and assembly
2013 StandoutNobel
Prospective Evaluation of Unexplained Chronic Liver Transaminase Abnormalities in Asymptomatic and Symptomatic Patients
1999
Telaprevir with Peginterferon and Ribavirin for Chronic HCV Genotype 1 Infection
2009
An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases
2011
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
2009 StandoutNature
State of Telehealth
2016 Standout
Hepatitis C Virus-Specific Directly Acting Antiviral Drugs
2013
Systematic review: anti-viral therapy of recurrent hepatitis C after liver transplantation
2010
Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
2010 Standout
Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity☆, ☆☆
1999 Standout
Bioavailability, pharmacokinetics, and pharmacodynamics of torsemide and furosemide in patients with congestive heart failure*
1995
Diuretic Combinations in Refractory Oedema States
1996
Understanding the hepatitis C virus life cycle paves the way for highly effective therapies
2013 StandoutNobel
A Hepatitis C Virus (HCV) Vaccine Comprising Envelope Glycoproteins gpE1/gpE2 Derived from a Single Isolate Elicits Broad Cross-Genotype Neutralizing Antibodies in Humans
2013 StandoutNobel
The Results of Phase III Clinical Trials With Telaprevir and Boceprevir Presented at the Liver Meeting 2010: A New Standard of Care for Hepatitis C Virus Genotype 1 Infection, But With Issues Still Pending
2011
Outcomes of Treatment for Hepatitis C Virus Infection by Primary Care Providers
2011
The dawn of a new era in HCV therapy
2011
Changes in sequences of core region, interferon sensitivity‐determining region and interferon and ribavirin resistance‐determining region of hepatitis C virus genotype 1 during interferon‐alpha and ribavirin therapy, and efficacy of retreatment
2012
Boceprevir for Untreated Chronic HCV Genotype 1 Infection
2011 Standout
Colonoscopic Polypectomy and Long-Term Prevention of Colorectal-Cancer Deaths
2012 Standout
Treatment of HCV Infection by Targeting MicroRNA
2013 Standout
Replication of hepatitis C virus
2007 StandoutNobel
Quality Indicators for Colonoscopy
2014
The role of neutralizing antibodies in hepatitis C virus infection
2011
Hepatitis C virus infects rhesus macaque hepatocytes and simianized mice
2015 StandoutNobel
Recombinant Hepatitis C Virus Envelope Glycoprotein Vaccine Elicits Antibodies Targeting Multiple Epitopes on the Envelope Glycoproteins Associated with Broad Cross-Neutralization
2014 StandoutNobel
Treatment of Hepatitis C
2014
Ultrastructural analysis of hepatitis C virus particles
2013 StandoutNobel
Deep Sequencing Reveals Mutagenic Effects of Ribavirin during Monotherapy of Hepatitis C Virus Genotype 1-Infected Patients
2013
Modeling host interactions with hepatitis B virus using primary and induced pluripotent stem cell-derived hepatocellular systems
2014 StandoutNobel
Broadly Neutralizing Immune Responses against Hepatitis C Virus Induced by Vectored Measles Viruses and a Recombinant Envelope Protein Booster
2012 StandoutNobel
Screening for Colorectal Cancer
2016 Standout
Systemic Complications of Acromegaly: Epidemiology, Pathogenesis, and Management
2004 Standout
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Molecular Genetics of Colorectal Cancer
2011
Quality Indicators for Colonoscopy
2006
Rational Tuning of Fluorobenzene Probes for Cysteine‐Selective Protein Modification
2018 StandoutNobel
Response of Hepatitis C Virus to Long-Term Passage in the Presence of Alpha Interferon: Multiple Mutations and a Common Phenotype
2013 StandoutNobel
Quality indicators for colonoscopy
2014 Standout
Loop diuretics: from the Na-K-2Cl transporter to clinical use
2003
Aromatic Sulfonyl Fluorides Covalently Kinetically Stabilize Transthyretin to Prevent Amyloidogenesis while Affording a Fluorescent Conjugate
2013 StandoutNobel
The resurgence of covalent drugs
2011
Variable Furosemide Absorption and Poor Predictability of Response in Elderly Patients
1997
A Heck–Matsuda Process for the Synthesis of β‐Arylethenesulfonyl Fluorides: Selectively Addressable Bis‐electrophiles for SuFEx Click Chemistry
2016 StandoutNobel
Replicons of a Rodent Hepatitis C Model Virus Permit Selection of Highly Permissive Cells
2019 StandoutNobel
Successful anti-scavenger receptor class B type I (SR-BI) monoclonal antibody therapy in humanized mice after challenge with HCV variants with in vitro resistance to SR-BI-targeting agents
2014 StandoutNobel
CLINICAL PERSPECTIVE: Acromegaly and Cancer: A Problem
2001
Palladium‐Catalyzed Fluorosulfonylvinylation of Organic Iodides
2017 StandoutNobel
Arylfluorosulfates Inactivate Intracellular Lipid Binding Protein(s) through Chemoselective SuFEx Reaction with a Binding Site Tyr Residue
2016 StandoutNobel
Internal Disequilibria and Phenotypic Diversification during Replication of Hepatitis C Virus in a Noncoevolving Cellular Environment
2017 StandoutNobel
Nonalcoholic Fatty Liver Disease
2015 Standout
Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965.
2012
Novel Therapies for Hepatitis C: Insights from the Structure of the Virus
2011
Toward a Hepatitis C Virus Vaccine: the Structural Basis of Hepatitis C Virus Neutralization by AP33, a Broadly Neutralizing Antibody
2012
“Inverse Drug Discovery” Strategy To Identify Proteins That Are Targeted by Latent Electrophiles As Exemplified by Aryl Fluorosulfates
2017 StandoutNobel
Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas
2004 StandoutNobel
ACG Clinical Guidelines: Colorectal Cancer Screening 2021
2021
Works of David Pound being referenced
Bioavailability, pharmacokinetics, and pharmacodynamics of torsemide in patients with cirrhosis
1993
Hepatitis C virus does not cause nonalcoholic steatohepatitis
1992
Transmission of Idiopathic (Autoimmune) Thrombocytopenic Purpura by Liver Transplantation
1990
Peginterferon alfa-2b and weight-based or flat-dose ribavirin in chronic hepatitis C patients
2007
Furosemide absorption in patients with cirrhosis
1991
Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial
2010
Multicentre, prospective, randomised study comparing the diagnostic yield of colon capsule endoscopy versus CT colonography in a screening population (the TOPAZ study)
2020
479 A MULTICENTER, PROSPECTIVE, RANDOMIZED STUDY COMPARING THE DIAGNOSTIC YIELD OF COLON CAPSULE ENDOSCOPY VERSUS COMPUTED TOMOGRAPHIC COLONOGRAPHY IN A SCREENING POPULATION. RESULTS OF THE TOPAZ STUDY
2019
Colonic neoplasia in asymptomatic persons with negative fecal occult blood tests: influence of age, gender, and family history.
1993
2016 LONG-TERM OUTCOMES FOLLOWING COMBINATION TREATMENT WITH BOCEPREVIR PLUS PEG-INTRON/RIBAVIRIN (P/R) IN PATIENTS WITH CHRONIC HEPATITIS C, GENOTYPE 1 (CHC-G1)
2010